Advertisement
Abcam (ABCM)
NASDAQ: ABCM
· Real-Time Price · USD
23.99
0.01 (0.04%)
At close: Dec 05, 2023, 9:00 PM
0.04% (1D)
| Bid | n/a |
| Market Cap | 5.52B |
| Revenue (ttm) | 458.15M |
| Net Income (ttm) | 275K |
| EPS (ttm) | 0.01 |
| PE Ratio (ttm) | 2399 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 7,430,229 |
| Avg. Volume (20D) | 5,816,355 |
| Open | 23.99 |
| Previous Close | 23.98 |
| Day's Range | 23.98 - 24.00 |
| 52-Week Range | 12.48 - 25.32 |
| Beta | 0.86 |
About ABCM
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 22, 2020
Employees 1,760
Stock Exchange NASDAQ
Ticker Symbol ABCM
Website https://www.abcam.com